☆ 4.6 Letter

Long-term cardiovascular burden in prostate cancer patients receiving androgen deprivation therapy

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。
Article Peripheral Vascular Disease

Relationship between angiotensin-converting enzyme inhibitors or angiotensin receptor blockers and COVID-19 incidence or severe disease

Gary Tse et al.

Summary: The study found a significant relationship between ACEI/ARB use and COVID-19 positivity and severe disease after adjusting for significant confounders. There were no significant differences in COVID-19 positivity or disease severity between ACEI and ARB use.

JOURNAL OF HYPERTENSION (2021)

添加到收藏夹
Article Oncology

Long-term outcomes of androgen deprivation therapy in prostate cancer among Japanese men over 80 years old

Leandro Blas et al.

Summary: This study examined the survival rate and risk of death from prostate cancer in men aged >= 80 y treated with primary androgen deprivation therapy. The findings suggest that immediate ADT may not be necessary for low- and intermediate-risk groups, but more efforts for curative therapy are needed for high- or very high-risk, regional, and metastatic prostate cancer patients.

CANCER SCIENCE (2021)

添加到收藏夹
Review Hematology

Cardiovascular Effects of Androgen Deprivation Therapy in Prostate Cancer: Contemporary Meta-Analyses

Jiun-Ruey Hu et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2020)

添加到收藏夹
Article Oncology

Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer

Nancy L. Keating et al.

JOURNAL OF CLINICAL ONCOLOGY (2006)

添加到收藏夹
研讨会 海报 问题 讨论圈 基金 期刊 论文 科研社交 资讯集成 审稿人 关于我们 常见问题 移动App 隐私条款 使用条款
© Peeref 2019-2024. All rights reserved.